SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition

Cancer

Volumn 119, Issue 12, 2013, Pages 2247-2257

  Xu, Jiangfeng ^a   Li, Xuedong ^a   Yang, Hao ^a   Chang, Ruimin ^a   Kong, Chenchen ^a   Yang, Lianyue ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

epithelial mesenchymal transition; hepatocellular carcinoma; invasion; metastasis; SAPK interacting protein 1

Indexed keywords

SAPK INTERACTING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR MECHANICS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR INVASION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; RNA, SMALL INTERFERING; UP-REGULATION; YOUNG ADULT;

EID: 84878541094     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28023     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Forner A, Llovet JM, Bruix J,. Hepatocellular carcinoma. Lancet. 2012; 379: 1245-1255.
3. Villanueva A, Hoshida Y, Battiston C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011; 140: 1501-1512.
4. Mayer J, Auriol J, Muscari F, et al. Worst prognosis of hypovascular hepatocellular carcinoma. J Hepatol. 2010; 52: 227.
5. Wang W, Wu F, Fang F, Tao YM, Yang LY,. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res. 2008; 14: 6804-6812.
6. Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C,. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology. 2009; 50: 1839-1850.
7. Fang F, Yang L, Tao Y, Qin W,. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer. 2012; 118: 134-146.
8. Fang F, Chang R, Yang L,. Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer. 2012; 118: 1782-1794.
9. Jacinto E, Facchinetti V, Liu D, et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127: 125-137.
10. Yang Q, Inoki K, Ikenoue T, Guan KL,. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 2006; 20: 2820-2832.
11. Lazorchak AS, Liu D, Facchinetti V, et al. Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Mol Cell. 2010; 39: 433-443.
12. Fang F, Luo LB, Tao YM, Wu F, Yang LY,. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2009; 18: 409-416.
13. Li Y, Tang ZY, Ye SL, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol. 2001; 7: 630-636.
14. Li Y, Tang Y, Ye L, et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol. 2003; 129: 43-51.
15. Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol. 2004; 130: 460-468.
16. Wang W, Yang LY, Huang GW, et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004; 90: 2349-2355.
17. Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F,. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009; 249: 118-123.
18. Fang Y, Xue JL, Shen Q, Chen J, Tian L,. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology. 2012; 55: 1852-1862.
19. Liu Y, Chen LH, Yuan YW, Li QS, Sun AM, Guan J,. Activation of AKT is associated with metastasis of nasopharyngeal carcinoma. Tumor Biol. 2012; 33: 241-245.
20. Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE,. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res. 2010; 70: 4151-4162.
21. Fu J, Chen Y, Cao J, et al. p28(GANK) overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1 alpha pathways. Hepatology. 2011; 53: 181-192.
22. Li B, Tsao SW, Li YY, et al. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer. 2009; 125: 2576-2585.
23. Yang E, Boire A, Agarwal A, et al. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res. 2009; 69: 6223-6231.
24. Sheng S, Qiao M, Pardee AB,. Metastasis and AKT activation. J Cell Physiol. 2009; 218: 451-454.
25. Ogunwobi OO, Wang T, Zhang L, Liu C,. Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2012; 27: 566-578.
26. Yoo YA, Kang MH, Lee HJ, et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 2011; 71: 7061-7070.
27. Kang MH, Kang HN, Kim JL, Kim JS, Oh SC, Yoo YA,. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep. 2009; 22: 525-534.
28. Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003; 63: 2172-2178.
29. Julien S, Puig I, Caretti E, et al. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene. 2007; 26: 7445-7456.
30. Lee TK, Poon TP, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006; 12: 5369-5376.
31. Thiery JP, Acloque H, Huang RY, Nieto MA,. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139: 871-890.
32. Tsuji T, Ibaragi S, Hu GF,. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009; 69: 7135-7139.
33. Christiansen J, Rajasekaran AK,. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006; 66: 8319-8326.
34. Singh A, Settleman J,. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 34: 4741-4751.